Inventor · disambiguated record
Riitta Lassila
Also filed as: LASSILA RIITTA
5 granted patents·4 pending applications·10 citations·filing 1998–2025
74Inventor score
Top patents by PatentIndex Score
9 records- 0176US7504113B2Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventionsJENNY JA ANTTI WIHURIN RAHASTO·Filed 2007·Granted Mar 17, 2009·4 cites·18 claims
- 0273US2025025536A1Therapeutic APAC Molecule Comprising Heparin Conjugated to a Plasma ProteinAPLAGON OY·Filed 2024·Application pending·0 cites
- 0369US12208132B2Therapeutic APAC molecule comprising heparin conjugated to a plasma proteinAPLAGON OY·Filed 2022·Granted Jan 28, 2025·0 cites·6 claims
- 0468US11446361B2Therapeutic APAC molecule comprising heparin conjugated to a plasma proteinAPLAGON OY·Filed 2015·Granted Sep 20, 2022·1 cites·15 claims
- 0566US7314860B2Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventionsJENNY JA ANTTI WIHURIN RAHASTO·Filed 2003·Granted Jan 1, 2008·4 cites·3 claims
- 0661US8415324B2Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventionsLASSILA RIITTA·Filed 2009·Granted Apr 9, 2013·1 cites·7 claims
- 0746US2023136745A1An antithrombic molecule having apac activity for the prevention and/or treatment of thrombocytopeniaAPLAGON OY·Filed 2021·Application pending·0 cites
- 0844US2025288651A1Therapeutic APAC Molecule Comprising Heparin Conjugated to a Plasma ProteinAPLAGON OY·Filed 2025·Application pending·0 cites
- 0923US2002016308A1Heparin-like compounds, their preparation and use to prevent arterial thrombsis associated with vascular injury and intervetionsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Riitta Lassila files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →